The integration of a DNA copy of the human immunodeficiency virus type 1 (HIV-1) genome into a chromosome of an infected cell is a pivotal step in virus replication. Integration requires the activity of the virus-encoded integrase, which enters the cell as a component of the virion. Results of numerous mutagenesis studies have identified amino acid residues and protein domains of HIV-1 integrase critical for in vitro activity, but only a few of these mutants have been studied for their effects on HIV replication. We have introduced site-directed changes into an infectious DNA clone of HIV-1 and show that integrase mutations can affect virus replication at a variety of steps. We identified mutations that altered virion morphology, levels of particleassociated integrase and reverse transcriptase, and viral DNA synthesis. One replication-defective mutant virus which had normal morphology and protein composition displayed increased levels of circular viral DNA following infection of a T-cell line. This virus also had a significant titer in a CD4-positive indicator cell assay, which requires the viral Tat protein. Although unintegrated viral DNA can serve as a template for Tat expression in infected indicator cells, this level of expression is insufficient to support a spreading viral infection in CD4-positive lymphocytes.
Three pol gene products, protease (PR), reverse transcriptase (RT), and integrase (IN), perform functions essential for human immunodeficiency virus type 1 (HIV-1) replication at different steps in the virus life cycle. PR processes viral polyprotein precursors into the mature virion. Soon after infection, RT, and its associated RNase H activity, copy the viral RNA genome into double-stranded blunt-ended DNA. In an initial processing reaction, IN cleaves this DNA near each 3Ј end, adjacent to the conserved dinucleotide CA. Following nuclear localization, IN joins the recessed CA OH ends to two 5Ј-phosphates in the two strands of a chromosomal target site by a pair of DNA strand transfer reactions. The 5Ј ends of the viral DNA and the 3Ј ends of the host DNA remain unjoined in the resulting integration intermediate. Repair of the intermediate, which is thought to be carried out by cellular enzymes, generates the integrated provirus. See reference 20 for a recent review of the roles of PR, RT, and IN in virus replication.
Purified HIV-1 IN exhibits both 3Ј processing and DNA strand transfer activities in vitro (3, 44, 53) . Reactions require substrates which mimic the ends of linear viral DNA, IN, and a divalent metal ion cofactor. HIV-1 IN also catalyzes an apparent reversal of the strand transfer reaction in vitro, a process termed disintegration (6) . In this reaction, branched oligonucleotide DNA substrates, composed of both viral and target DNA sequences, are resolved into their separate viral and target DNA components.
Mutational analyses of HIV-1 IN indicate that the protein consists of three functional domains: the N-terminal, core, and C-terminal domains. Deletion mutagenesis has shown that all three domains are required for 3Ј processing and DNA strand transfer in vitro (7, 43, 52) , whereas the core domain is sufficient for disintegration activity (4, 32) . The core domain is composed of two subdomains; one part, originally identified as a relatively protease resistant fragment of HIV-1 IN (9), contains the D,D-35-E amino acid sequence motif (9, 24) . This motif is conserved in the integrases of retroviruses and retrotransposons, as well as in the transposases of some bacterial transposons (2, 14, 24, 36, 40) . Certain single amino acid substitutions of the Asp and Glu residues which compose the motif abolish the 3Ј processing, DNA strand transfer, and disintegration activities of HIV-1 IN in vitro (9, 26, 48) , demonstrating the importance of each residue in the catalysis of polynucleotidyl transfer. The other part of the core domain lies C terminal to the protease-resistant fragment and is necessary for both the DNA binding and disintegration activities of the domain (11) . In addition to its central role in catalysis, the core domain contributes to interactions between integrase protomers (8, 19, 32, 49) .
The hypothesis that the conserved residues of the D,D-35-E sequence motif form part of a common IN active site is supported by the result that both 3Ј processing and DNA strand transfer are one-step transesterification reactions (12) . The functions of the N-and C-terminal domains in the 3Ј processing and DNA strand transfer reactions in vitro are less well understood than those of the core domain. The C-terminal domain is important for nonspecific binding of intact HIV-1 IN to DNA in vitro (11, 52, 57) and therefore may interact with target DNA during DNA strand transfer. Although the precise roles of the terminal domains in the 3Ј processing and DNA strand transfer reactions are unknown, the N-or C-terminal functions, and the core functions, can be provided by separate polypeptides in reactions that contain a pair of mutant IN proteins (8, 49) .
In this study, the effects of mutations on IN function were investigated by introducing changes into an infectious molecular clone of HIV-1 NL4-3 and assaying virus replication. Our results confirm that IN mutations can disrupt the viral life cycle at different steps (45) . A majority of the mutations altered particle morphology following transfection of CD4-negative cell lines and altered viral DNA synthesis after infection of the T-cell line CEM-12D7.
MATERIALS AND METHODS
Construction of mutant HIV-1 proviral DNAs. A PCR-based mutagenesis strategy was used to introduce site-directed mutations in the pol gene of pNL4-3, an infectious plasmid DNA clone of HIV-1 NL4-3 (1) . Each mutation was incorporated into a convenient restriction site fragment by using two successive PCRs essentially as previously described (17) . The first set of reactions used pNL4-3 as a template to generate the two halves of the fragment, each half containing a restriction site near one end and the mutation near the other end. The mutagenic primers were chosen so that the ends of the halves which contained the mutation overlapped. The full-length fragment was generated by using the overlapping halves as the template and the two primers that contained the restriction sites. PCR mixtures contained 4 ng of DNA template and 5 ng of each primer per ml and 2 U of Vent DNA polymerase (New England Biolabs, Beverly, Mass.), using buffer conditions specified by the manufacturer. Reaction mixtures were kept at 96ЊC for 2 min and then subjected to 20 cycles of denaturation at 96ЊC (15 s), annealing at 58ЊC (1 min), and extension at 74ЊC (45 s). Amplified fragments were purified following polyacrylamide gel electrophoresis (PAGE).
IN mutations were incorporated into the AgeI-PflMI fragment between bases 3485 and 5297 (33) . The 1-234 and 1-4 deletion mutations were made by introducing termination codons after the codons encoding Val-234 and Gly-4, respectively. For the 1-234 mutation, 5Ј-GTTTGGAAAGGA was changed to 5Ј-GTT TGATAATGA, where 5Ј-GTT encodes Val-234. For 1-4, 5Ј-GGAATAGATA AGGCC was changed to 5Ј-GGATAGTAATAGCC, where 5Ј-GGA encodes Gly-4 and the underlined base was deleted.
The single base substitution G3A at position 3105, encoding the amino acid substitution Asp-1863Asn in the active site of RT, was incorporated into the ApaI-AgeI fragment between bases 2006 and 3485. Following digestion with restriction endonucleases, the PCR-amplified fragments were ligated with the appropriately digested, gel-purified pNL4-3 DNA backbone by using standard techniques (41) . The regions of the resulting plasmids synthesized by PCR were sequenced by the chain termination method (42) .
Cells and viruses. HeLa and 293 cells were grown in Dulbecco modified Eagle medium (DMEM) supplemented to contain 5 and 10% fetal calf serum, respectively, 100 U of penicillin G sodium, and 0.1 mg of streptomycin sulfate per ml. Cells were plated at 3.6 ϫ 10 4 cells per cm 2 16 h prior to transfection. Virus stocks were prepared by transfecting cells with 10 g of plasmid DNA in the presence of calcium phosphate, using the Stratagene (La Jolla, Calif.) mammalian transfection kit and 10 6 293 cells or the Pharmacia (Piscataway, N.J.) CellPhect kit and 3.5 ϫ 10 5 HeLa cells. Culture supernatants were tested for Mg 2ϩ -dependent 32 P-RT activity 48 h posttransfection essentially as previously described (55) . Supernatants were filtered through 0.45-m-pore-size nitrocellulose, and equal 32 P-RT counts per minute of wild-type HIV-1 NL4-3 and mutant viruses were used in subsequent infections. Phenotypically mixed virus particles were made by mixing plasmid DNAs prior to transfection.
CEM-12D7 cells (37) , a subclone of the CEM-A3.01 human T-cell line (15), were grown in RPMI 1640 supplemented to contain 10% fetal calf serum, 100 U of penicillin G sodium, and 0.1 mg of streptomycin sulfate per ml. Cells (2.5 ϫ 10 6 ) were infected with 2.5 ϫ 10 5 32 P-RT cpm in 0.5 ml of RPMI 1640 for 1 h at 37ЊC prior to addition of 5 ml of RPMI 1640 supplemented with 10% fetal calf serum. Cultures were fed at 2-day intervals, and aliquots of the medium were assayed for 32 P-RT activity. Each mutant virus was tested in at least two independent experiments.
The CD4-LTR/␤-gal indicator cell line, obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, from Michael Emerman (22) , was maintained in DMEM supplemented to contain 10% fetal calf serum, 100 U of penicillin G sodium, 0.1 mg of streptomycin sulfate, 0.2 mg of G418 sulfate, and 0.1 mg of hygromycin B per ml. Cells were seeded at 0.4 ϫ 10 5 cells per well of a 24-well plate 24 h prior to infection. Virus (150 l) was adsorbed in the presence of 3 g of DEAE-dextran for 2 h at 37ЊC prior to addition of 1 ml of medium. The cells were fixed and stained with 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) 48 h postinfection as previously described (22) .
Analysis of HIV-1 proteins. Both cell-and particle-associated HIV-1 proteins were analyzed by radiolabeling transfected HeLa cells and immunoprecipitation with AIDS patient antisera (obtained through the AIDS Research and Reference Reagent Program from Alfred Prince) (34, 35) essentially as previously described (16, 54) . Lysates of pelleted virions were also immunoprecipitated with 40 l of rabbit polyclonal antisera (Assay Research, Inc., College Park, Md.) generated against purified recombinant HIV-1 IN.
Quantitation of immunoprecipitated proteins was done with a PhosphorImager using ImageQuant 3.3 (Molecular Dynamics, Sunnyvale, Calif.) and on a Macintosh Quadra 650 using the public domain NIH Image program (written by Wayne Rasband at the National Institutes of Health and available from the Internet by anonymous ftp from zippy.nimh.nih.gov or on floppy disk from NTIS, 5285 Port Royal Rd., Springfield, VA 22161, part no. PB93-504868).
Analysis of viral DNA synthesis. Viral DNA synthesis was analyzed by PCR using primers which amplify sequences from the two-long-terminal-repeat (LTR)-containing circle formed in the nuclei of infected cells (50) . The sequences of the primers and corresponding positions (33) in pNL4-3 (only one set of LTR positions is given) are 5Ј-GAGATCCCTCAGACCCTTTTAG (positive strand of U5, bases 9666 to 9687) and 5Ј-GTCAGTGGATATCTGATCCCTG (negative strand of U3, bases 124 to 103).
CEM-12D7 cells (3.0 ϫ 10 6 ) were infected with 3.0 ϫ 10 5 32 P-RT cpm of each virus as described above. The cells were washed with 1 ml of DMEM 18 h postinfection and resuspended in 0.25 ml of DMEM. RQ1 RNase-free DNase (20 U; Promega Corporation, Madison, Wis.) was added for 20 min at 37ЊC to digest residual plasmid DNA. Trypsin (Gibco BRL Life Technologies) was added to the final concentration 0.005% (wt/vol), and the mixture was incubated at 37ЊC for 10 min to degrade the DNase. The cells were washed twice with 1 ml of phosphate-buffered saline (PBS) and lysed in 0.5 ml of 10 mM Tris-HCl (pH 8.1)-1 mM EDTA-0.001% (vol/vol) Triton X-100-0.0001% (wt/vol) sodium dodecyl sulfate (SDS). Proteinase K (50 g) was added, and the lysates were heated at 56ЊC for 1 h and then at 95ЊC for 10 min.
PCR mixtures contained 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.75 mM MgCl 2 , 0.02% (wt/vol) gelatin, 0.2 mM each deoxynucleoside triphosphate, 1 M each primer, 25 l of infected cell lysate (corresponding to approximately 1 g of total DNA), and 1.25 U of AmpliTaq DNA polymerase (Perkin-Elmer, Roche Molecular Systems, Inc., Branchburg, N.J.) in a volume of 50 l. The reaction components were mixed at room temperature, overlaid with 70 l of light mineral oil, and heated to 94ЊC prior to addition of the DNA polymerase. Thirty-four cycles of denaturation, annealing, and polymerization were performed at 94ЊC (45 s), 60ЊC (30 s), and 72ЊC (2 min), respectively. Portions (10 l) of each reaction mixture were electrophoresed in 6% polyacrylamide gels (Novex, San Diego, Calif.). Gels were stained with 0.5 g of ethidium bromide per ml to visualize the DNA.
Electron microscopy. HeLa cells were transfected with 10 g of plasmid DNA as described above. Two days posttransfection, cells were washed once with cold PBS, and 2.5% (vol/vol) glutaraldehyde (Sigma no. G5882) in PBS was added. Cells were fixed at 4ЊC for at least 24 h and processed for thin-section microscopy as previously described (16) .
RESULTS
Mutagenesis strategy. HIV-1 IN contains three distinct functional domains: the N-terminal, core, and C-terminal domains. Each of the domains is required for IN activity in assays for 3Ј processing and DNA strand transfer in vitro (4, 7, 9, 24, 26, 43, 48, 51, 52) . Mixtures of certain pairs of mutant IN proteins, however, are able to complement these in vitro activities (8, 49) . The original goal of this study was to test the effects of mutations in each of the IN protein domains on replication of HIV-1 in cell culture. A separate goal was to explore whether virions containing two different mutant IN proteins within the same virus particle could integrate HIV DNA in a single round of infection.
Mutations were introduced into pNL4-3, an infectious proviral DNA clone of HIV-1 (1), and virus stocks were produced by transfecting HeLa or 293 cells. Transient transfection of CD4-negative cells bypasses the early steps in replication, such as receptor-mediated entry, reverse transcription, and integration. The infectivity of virus released into cell supernatants was assayed in the human T-cell leukemia line CEM-12D7 (37) . Infectivity was also evaluated in a single cycle by using the HeLa-derived indicator cell line CD4-LTR/␤-gal (22) . This cell line contains a copy of the ␤-galactosidase gene under the control of the HIV-1 LTR. Following infection and presumed integration of viral DNA, newly synthesized Tat protein transactivates the expression of ␤-galactosidase, which in turn causes the nuclei of infected cells to appear blue after staining with X-Gal. This assay has been termed MAGI, for multinuclear activation of galactosidase indicator (22) .
HIV-1 IN/H12N was selected as an N-terminal domain IN point mutant, and HIV-1 IN/1-234 (1-234 refers to the amino acid residues retained) was selected as a C-terminal domain deletion mutant (Fig. 1) ; an N-terminal deletion mutant was not included since it would disrupt the protease cleavage site between the RT and IN domains in the Gag-Pol polyprotein precursor. HIV-1 IN/D116N was chosen as a core domain mutant on the basis of the putative role of Asp-116 in the catalysis of 3Ј processing, DNA strand transfer, and disintegration (9, 26, 48) . A single amino acid residue in the C-terminal domain, Trp-235, was targeted because it is conserved among retroviral IN proteins (Fig. 1) . Finally, a single base deletion and three stop codons were engineered after the fourth codon in the IN reading frame, to produce the integrase-minus mutant HIV-
It has recently been reported that phenotypically mixed Moloney murine leukemia virus (Mo-MLV) particles, produced by transfecting two viral genomes carrying separate mutations in pol, are capable of complementing for virus growth (47) . In that study, infectivity was demonstrated with virus inocula containing defective forms of RT and IN within individual particles. Might similar phenotypically mixed HIV-1 particles function in a single round of infection? We engineered the amino acid substitution Asp-1863Asn in one of the active-site residues (23, 27, 31) The replication-defective phenotypes may be due solely to the inability of the mutant INs to promote these reactions after infection. However, it is also possible these mutations affect other steps in the virus life cycle. For example, proper processing of the Gag-Pol precursor during virus assembly, or the reverse transcription reaction, may be impaired. Although we knew that each mutant IN plasmid produced detectable 32 P-RT activity in culture supernatants following transfection, the integrity of the resulting virions, as well as the capacity of RT to function in the next infectious cycle, was unknown.
Transfected cells were radiolabeled, and cell-and particleassociated lysates were analyzed by immunoprecipitation to visualize HIV-1 proteins. Analysis of HeLa cells expressing HIV-1 NL4-3 revealed the presence of the expected precursor and mature forms of the envelope and Gag proteins (Fig. 3A,  lane 1) . Each of the mutant plasmid DNAs also directed the expression of these proteins in proportions roughly equal to wild type, although the overall level of expression was reduced two-to threefold in the cases of HIV- 1 IN/H12N , HIV-1 IN/1-234 , and HIV-1 IN/1-4 (Fig. 3A) . Analysis of pelleted culture super- FIG. 1. IN protein domains and mutations. In the diagram of the 288-residue wild-type protein, the three domains defined by complementation in vitro (8, 49) are shown. The N-terminal domain contains two His and two Cys residues which are conserved in retroviral and retrotransposon IN proteins (9, 18, 21, 51) . The core domain contains three putative active-site residues, Asp-64, Asp-116, and Glu-152, which are conserved in certain bacterial transposases in addition to being conserved in retroviral and retrotransposon IN (2, 14, 24, 36, 40) . The C-terminal domain contains a single amino acid residue, Trp-235, which is conserved only among retroviral IN (10, 30) . The residues altered by point mutation are marked (*). The lines alongside the two deletion mutations depict the sizes of the proteins relative to wild-type IN. 
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natants revealed each contained near normal levels of the capsid (CA) protein, except for HIV-1 IN/1-4 , which had approximately threefold less (Fig. 3B) . A longer exposure of the gel in Fig. 3B revealed additional virion proteins, including two products of pol, the p66 subunit of RT and IN (Fig. 3C, lane 1) . HIV-1 IN/D116N and HIV-1 RT/D186N each contained wild-type levels of protein (lanes 3 and 6). In contrast, HIV-1 IN/H12N , HIV-1 IN/1-234 , and HIV-1 IN/1-4 particles contained reduced amounts of certain proteins. When normalized to the levels of CA and surface (SU) envelope glycoprotein, it was evident these viruses contained between three-and fivefold reductions of p66(RT) (lanes 2, 4, and 5). The level of IN in HIV-1 IN/H12N was also reduced to at least this level. Detection of the 1-234 truncated mutant IN protein, which is close in size to CA, was difficult using AIDS patient antisera. Radiolabeled particles were therefore also analyzed by immunoprecipitation using a polyclonal antisera raised against purified recombinant HIV-1 IN.
This experiment again showed that HIV-1 NL4-3 , HIV-1 IN/D116N , and HIV-1 RT/D186N contained similar levels of IN (Fig. 4, lanes 1, 3, and 6 ). 
Effects of IN mutations on virion morphology.
To obtain a more detailed view of the effects that some of the IN mutations had on particle formation, thin sections of transfected HeLa cells were analyzed by electron microscopy. Analysis of cells expressing wild-type HIV-1 NL4-3 revealed mature particles containing typical conical nucleoids (Fig. 5A) gag under our electrophoresis conditions. These two proteins were separated in cells expressing HIV-1 RT/D186N , probably because the D186N amino acid substitution caused both the p66 and p51 subunits to display slightly faster electrophoretic mobilities. Similar changes in electrophoretic mobility have been observed for recombinant RT/D186N expressed in Escherichia coli (27, 31) . The exposure was for approximately 5 weeks at Ϫ70ЊC. Other labeling is the same as in panel A.
FIG. 4. Analysis of particle-associated proteins, using polyclonal antisera against wild-type IN. Lanes 1 to 7 contain particle lysates as described for lanes 1 to 7 in Fig. 3B . The immunoprecipitants were electrophoresed in a 8 to 16% gradient SDS-polyacrylamide gel (Novex). The gel was exposed to film for approximately 10 weeks at Ϫ70ЊC. and HIV-1 RT/D186N particles for the most part had a similar morphology (Fig. 5B and data not shown) . In contrast to the relatively benign effects of the IN and RT active-site mutations on morphology, the H12N, 1-234, and 1-4 IN mutations affected the appearance of virus particles. Although there were some late-budding forms, most were either immature rings or aberrant mature particles (Fig. 5C ). Either the latter were totally devoid of electron-dense nucleoid material or the material was situated between the empty nucleoid and the membrane (Fig. 5C to E) . The empty nucleoids were pleomorphic instead of the typical conical or bar shape.
IN mutations and viral DNA synthesis. Viral DNA synthesis was analyzed by PCR 18 h after infection, using primers which amplify sequences unique to the two-LTR-containing circle formed in the nuclei of infected cells by end-to-end ligation of linear viral DNA (50) . This analysis revealed amplified fragments of the appropriate sizes in cells infected with HIV- (Fig. 6) . Interestingly, the signal from cells infected with HIV-1 IN/D116N was consistently more intense than the signal following infection with the other viruses, including the wild type (compare lane 3 with lane 1). PCR using primers which amplify sequences between R and gag (58) showed that this region of viral DNA was present in equal amounts in cells infected with HIV-1 NL4-3 and HIV-1 IN/D116N (10) . Cells infected with HIV-1 IN/D116N apparently contained relatively more of the two-LTR circular form of viral DNA.
HIV-1 IN/D116N displays a significant titer in the MAGI assay. The infectivity of HIV-1 NL4-3 and each mutant virus was measured in a single round by using the MAGI assay. As (Table 1) . Similar titers were observed when virus stocks derived from three independent IN/D116N mutant plasmid DNA constructs were used. Although we originally planned to test complementation of individual virus particles containing a pair of mutant IN proteins for the ability to integrate viral DNA, our protein, ultrastructural, and DNA analyses suggested that the majority of mutations that we engineered into HIV-1 might not be well suited for this purpose. For example, the H12N, 1-234, and 1-4 mutations reduced the levels of particle-associated IN and RT and affected virion morphology. In addition, these mutations reduced the levels of viral DNA synthesized following infection (Fig. 6 and data not shown). Despite these shortcomings, the infectivity of phenotypically mixed particles generated by cotransfecting cells with two different IN mutant plasmids was monitored with the MAGI assay. We also assayed the infectivity of viruses containing a mixture of the separate IN mutants and RT/D186N, as it has recently been reported that RT and IN mutants of Mo-MLV are able to complement virus growth (47) .
Infection with phenotypically mixed particles did not yield any increase in the number of blue-stained cells from that observed with the individual mutant viruses (10) . This was the case for viruses produced by transfecting two IN mutant plasmids, as well as mixtures of the RT/D186N and different mutant IN plasmids. The ratios of the two plasmids were varied prior to transfection to reflect the relative differences of CA in the individual mutant viruses (Fig. 3B) . Particles produced from these transfections also did not show any sign of complementation.
DISCUSSION
Our results emphasize the importance of exercising caution in interpreting the effects of IN mutations on virus replication. Although most of the mutant virions that we constructed were expected to be replication defective because the mutation diminishes IN activity in vitro, many were found to exhibit defects at other stages of the viral replication cycle. One mutation, IN/D116N, that maintained normal virion morphology and protein composition exhibited two interesting properties. The two-LTR circular form of viral DNA accumulated to higher levels than with the wild-type virus following infection of CEM-12D7 cells, and although the mutant virus was unable to spread throughout the culture and generate progeny virions as detected by RT assays (Fig. 2A) , a significant titer of blue cells was observed with the MAGI assay ( Table 1) . We conclude that IN-mediated DNA integration is essential for infectivity in CD4-positive lymphocytes but not in HeLa-CD4 cells as monitored by the MAGI assay.
Replication of HIV-1 containing IN mutations. A single amino acid residue in the C-terminal domain of HIV-1 IN, Trp-235, is conserved among retroviral IN proteins (10, 30) . Since the amino acid substitution Trp-2353Glu has no detectable effects on the activities of IN in vitro (26) , it was of interest to determine whether this residue might be functionally important for replication of HIV-1 in cell culture. We found that HIV-1 IN/W235F exhibited wild-type replication kinetics in CEM-12D7 cells. It is possible that the high degree of conservation of this residue reflects a selective advantage under some growth conditions which are not detected in this assay. It is interesting that HIV-1 carrying the substitution Trp-2353Ala is unable to replicate in cell culture (5) a Cells which contained dark blue nuclei were counted. Each value is the average number from at least three independent infections.
b HIV-1 RT/D186N did not display detectable 32 P-RT activity. The virus inoculum was based on the level of particle-associated CA relative to HIV-1 (Fig.  3B) . (9 (Fig. 3 and 4) . These mutations probably perturbed the levels at which the Gag-Pol precursors were incorporated into virus particles and/or the proper processing of the precursors after incorporation. Electron microscopy of cells expressing HIV- 1 IN/H12N , HIV-1 IN/1-234 , and HIV-1 IN/1-4 revealed alterations in virion morphogenesis and maturation. Typical conical nucleoids with electron-dense broad ends were rarely, if ever, formed. The electron-dense material was either extranucleoid or apparently absent, and the core was often misshapen (Fig. 5 ). These results demonstrate that relatively small changes in IN, for example, the single amino acid substitution His123Asn, can markedly affect virus assembly and maturation.
Certain Mo-MLV and HIV-1 IN mutations have previously been shown to alter the protein composition of virus particles. For Mo-MLV, some N-terminal, core, and C-terminal domain mutations have led to lower levels of RT and IN (38, 39) . Similar affects have been described for some core domain mutants of HIV-1 (5, 45, 46 ). An integrase-minus deletion mutant similar to HIV-1 IN/1-4 displayed a comparable phenotype (13) .
HIV-1 gene expression from unintegrated viral DNA. The phenotype of HIV-1 IN/D116N was particularly interesting. PCR with a pair of primers that amplify across the two-LTR circle junction revealed that CEM-12D7 cells infected with HIV-1 IN/D116N contained more circular viral DNA than did cells infected with wild-type HIV-1 NL4-3 . Although virus replication was not detected by RT assays of culture supernatants after infection of CEM-12D7 cells, an unexpectedly high infectivity was obtained when the MAGI assay was used. Unlike the other IN mutations reported here which rendered HIV-1 replication defective, mutation of this putative catalytic site residue did not affect the incorporation and/or processing of Gag-Pol during particle assembly and maturation. Therefore, the early phase of the virus life cycle most likely proceeded normally up to the 3Ј processing step of integration. Two factors may account for the increased abundance of two-LTR-circle DNA in CEM-12D7 cells infected with HIV-1 IN/D116N . First, the absence of 3Ј processing activity by the mutant IN would result in maintenance of the blunt viral DNA ends, which would be a better substrate for host DNA ligase than a pair of processed ends. Second, because HIV-1 IN/D116N DNA is unable to integrate, potentially more linear molecules would be available for ligation.
The significant titer in the MAGI assay indicates the presence of Tat in the nuclei of CD4-LTR/␤-gal cells infected with HIV-1 IN/D116N . Expression of ␤-galactosidase is not induced when these cells are infected with wild-type HIV-1 in the presence of azidothymidine (28) , apparently demonstrating a requirement for reverse transcription and excluding the possibility that expression can be turned on by Tat which may enter the cell with the virus. Consistent with this finding, HIV-1 RT/ D186N did not transactivate ␤-galactosidase expression following infection (Table 1) . A simple interpretation of our results is CD4-LTR/␤-gal cells infected with HIV-1 IN/D116N accumulated unintegrated DNA, and this DNA served as a template for Tat expression. This level of expression, even if it occurs in CEM-12D7 cells infected with HIV-1 IN/D116N , is insufficient to support a spreading infection.
